133 related articles for article (PubMed ID: 33538660)
21. High-throughput screen for inhibitors of protein-protein interactions in a reconstituted heat shock protein 70 (Hsp70) complex.
Taylor IR; Dunyak BM; Komiyama T; Shao H; Ran X; Assimon VA; Kalyanaraman C; Rauch JN; Jacobson MP; Zuiderweg ERP; Gestwicki JE
J Biol Chem; 2018 Mar; 293(11):4014-4025. PubMed ID: 29414793
[TBL] [Abstract][Full Text] [Related]
22. VER-155008, a small molecule inhibitor of HSP70 with potent anti-cancer activity on lung cancer cell lines.
Wen W; Liu W; Shao Y; Chen L
Exp Biol Med (Maywood); 2014 May; 239(5):638-45. PubMed ID: 24676905
[TBL] [Abstract][Full Text] [Related]
23. HSP90 and HSP70: Implication in Inflammation Processes and Therapeutic Approaches for Myeloproliferative Neoplasms.
Sevin M; Girodon F; Garrido C; de Thonel A
Mediators Inflamm; 2015; 2015():970242. PubMed ID: 26549943
[TBL] [Abstract][Full Text] [Related]
24. The Role of HSP70 in Cancer and its Exploitation as a Therapeutic Target.
Martinková V; Trčka F; Vojtěšek B; Müller P
Klin Onkol; 2018; 31(Suppl 2):46-54. PubMed ID: 31023024
[TBL] [Abstract][Full Text] [Related]
25. Targeting Allosteric Control Mechanisms in Heat Shock Protein 70 (Hsp70).
Li X; Shao H; Taylor IR; Gestwicki JE
Curr Top Med Chem; 2016; 16(25):2729-40. PubMed ID: 27072701
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of HSP70: a challenging anti-cancer strategy.
Goloudina AR; Demidov ON; Garrido C
Cancer Lett; 2012 Dec; 325(2):117-24. PubMed ID: 22750096
[TBL] [Abstract][Full Text] [Related]
27. Quantitative proteomics of the yeast Hsp70/Hsp90 interactomes during DNA damage reveal chaperone-dependent regulation of ribonucleotide reductase.
Truman AW; Kristjansdottir K; Wolfgeher D; Ricco N; Mayampurath A; Volchenboum SL; Clotet J; Kron SJ
J Proteomics; 2015 Jan; 112():285-300. PubMed ID: 25452130
[TBL] [Abstract][Full Text] [Related]
28. Targeting HSP70: the second potentially druggable heat shock protein and molecular chaperone?
Powers MV; Jones K; Barillari C; Westwood I; van Montfort RL; Workman P
Cell Cycle; 2010 Apr; 9(8):1542-50. PubMed ID: 20372081
[TBL] [Abstract][Full Text] [Related]
29. Discovery of 5-aryl-3-thiophen-2-yl-1H-pyrazoles as a new class of Hsp90 inhibitors in hepatocellular carcinoma.
Mohamady S; Ismail MI; Mogheith SM; Attia YM; Taylor SD
Bioorg Chem; 2020 Jan; 94():103433. PubMed ID: 31785857
[TBL] [Abstract][Full Text] [Related]
30. Heat shock protein inhibitors increase the efficacy of measles virotherapy.
Liu C; Erlichman C; McDonald CJ; Ingle JN; Zollman P; Iankov I; Russell SJ; Galanis E
Gene Ther; 2008 Jul; 15(14):1024-34. PubMed ID: 18356818
[TBL] [Abstract][Full Text] [Related]
31. Heat Shock Protein 70 (Hsp70) Suppresses RIP1-Dependent Apoptotic and Necroptotic Cascades.
Srinivasan SR; Cesa LC; Li X; Julien O; Zhuang M; Shao H; Chung J; Maillard I; Wells JA; Duckett CS; Gestwicki JE
Mol Cancer Res; 2018 Jan; 16(1):58-68. PubMed ID: 28970360
[TBL] [Abstract][Full Text] [Related]
32. Intravenous Immunoglobulin G Suppresses Heat Shock Protein (HSP)-70 Expression and Enhances the Activity of HSP90 and Proteasome Inhibitors.
Jones RJ; Singh RK; Shirazi F; Wan J; Wang H; Wang X; Ha MJ; Baljevic M; Kuiatse I; Davis RE; Orlowski RZ
Front Immunol; 2020; 11():1816. PubMed ID: 32903557
[TBL] [Abstract][Full Text] [Related]
33. The Major Heat Shock Proteins, Hsp70 and Hsp90, in 2-Methoxyestradiol-Mediated Osteosarcoma Cell Death Model.
Gorska-Ponikowska M; Kuban-Jankowska A; Marino Gammazza A; Daca A; Wierzbicka JM; Zmijewski MA; Luu HH; Wozniak M; Cappello F
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963524
[TBL] [Abstract][Full Text] [Related]
34. Suppression of heat shock protein 27 using OGX-427 induces endoplasmic reticulum stress and potentiates heat shock protein 90 inhibitors to delay castrate-resistant prostate cancer.
Lamoureux F; Thomas C; Yin MJ; Fazli L; Zoubeidi A; Gleave ME
Eur Urol; 2014 Jul; 66(1):145-55. PubMed ID: 24411988
[TBL] [Abstract][Full Text] [Related]
35. Design and synthesis of piperidine derivatives as novel human heat shock protein 70 inhibitors for the treatment of drug-resistant tumors.
Zeng Y; Cao R; Zhang T; Li S; Zhong W
Eur J Med Chem; 2015 Jun; 97():19-31. PubMed ID: 25935385
[TBL] [Abstract][Full Text] [Related]
36. Allosteric Modulators of HSP90 and HSP70: Dynamics Meets Function through Structure-Based Drug Design.
Ferraro M; D'Annessa I; Moroni E; Morra G; Paladino A; Rinaldi S; Compostella F; Colombo G
J Med Chem; 2019 Jan; 62(1):60-87. PubMed ID: 30048133
[TBL] [Abstract][Full Text] [Related]
37. The natural compound cantharidin induces cancer cell death through inhibition of heat shock protein 70 (HSP70) and Bcl-2-associated athanogene domain 3 (BAG3) expression by blocking heat shock factor 1 (HSF1) binding to promoters.
Kim JA; Kim Y; Kwon BM; Han DC
J Biol Chem; 2013 Oct; 288(40):28713-26. PubMed ID: 23983126
[TBL] [Abstract][Full Text] [Related]
38. The Hsp70 inhibiting peptide aptamer A17 potentiates radiosensitization of tumor cells by Hsp90 inhibition.
Schilling D; Garrido C; Combs SE; Multhoff G
Cancer Lett; 2017 Apr; 390():146-152. PubMed ID: 28108313
[TBL] [Abstract][Full Text] [Related]
39. CAIR-1/BAG-3 abrogates heat shock protein-70 chaperone complex-mediated protein degradation: accumulation of poly-ubiquitinated Hsp90 client proteins.
Doong H; Rizzo K; Fang S; Kulpa V; Weissman AM; Kohn EC
J Biol Chem; 2003 Aug; 278(31):28490-500. PubMed ID: 12750378
[TBL] [Abstract][Full Text] [Related]
40. PI3K/Akt is required for heat shock proteins to protect hypoxia-inducible factor 1alpha from pVHL-independent degradation.
Zhou J; Schmid T; Frank R; Brüne B
J Biol Chem; 2004 Apr; 279(14):13506-13. PubMed ID: 14726529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
